Complex formation of amphotericin B in sterol-containing membranes as evidenced by surface plasmon resonance

Biochemistry

Volumn 47, Issue 30, 2008, Pages 7807-7815

  Mouri, Ryota ^a,b   Konoki, Keiichi ^a   Matsumori, Nobuaki ^a   Oishi, Tohru ^a   Murata, Michio ^a  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN FOOD RESEARCH LABORATORIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; ARSENIC COMPOUNDS; CELL MEMBRANES; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; DRUG INTERACTIONS; FLOW INTERACTIONS; HEALTH; LIPOSOMES; PHOSPHOLIPIDS; PLASMONS; RESONANCE; SURFACE PLASMON RESONANCE; SURFACE REACTIONS; THEOREM PROVING;

AMERICAN CHEMICAL SOCIETY (ACS); AMPHOTERICIN B; ASSOCIATION CONSTANTS; COMPLEX FORMATIONS; DYNAMIC PROCESSES; INTERACTION MODELING; INTRIGUING QUESTIONS; ION CHANNELLING; KINETIC ANALYSES; MEMBRANE-BOUND; NONSPECIFIC BINDINGS; ORDER-OF MAGNITUDES; PHOSPHOLIPID LIPOSOMES; REAL TIME OBSERVATIONS; RELIABLE METHOD; SENSOR CHIPS; SENSORGRAM; SIGNIFICANT REDUCTION; SURFACE PLASMON (SP); SURFACE PLASMON RESONANCE (SPR); TWO-STATE;

MEMBRANES;

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; AMPHOTERICIN B; ANTIBIOTIC AGENT; CHOLESTEROL; ERGOSTEROL; LIPOSOME; STEROL;

ARTICLE; BINDING KINETICS; CHEMICAL REACTION KINETICS; COMPLEX FORMATION; DRUG BINDING; MEMBRANE BINDING; MOLECULAR INTERACTION; MOLECULAR SENSOR; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

AMPHOTERICIN B; CHOLESTEROL; ERGOSTEROL; LIPOSOMES; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PHOSPHATIDYLCHOLINES; STEROLS; SURFACE PLASMON RESONANCE;

EID: 48249090423     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi800334p     Document Type: Article

References (50)

1. Gallis, H. A., Drew, R. H., and Pickard, W. W. (1990) Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12, 308-329.
2. Hann, I. M., and Prentice, H. G. (2001) Lipid-based amphotericin B: A review of the last 10 years of use. Int. J. Antimicrob. Agents 17, 161-169.
3. Gold, W., Stout, H. A., Pagano, J. F., and Donovie, R. (1955) Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies. Antibiot. Annu., 579-586.
4. Sternberg, T. H., Wright, E. T., and Oura, M. (1956) A new antifungal antibiotic, amphotericin B. Antibiot. Annu., 566-573.
5. Mechlinski, W., Schaffner, C. P., Ganis, P., and Avitabile, G. (1970) Structure and absolute configuration of the polyene macrolide antibiotic amphotericin B. Tetrahedron Lett. 44, 3873-3876.
6. Ganis, P., Auitabile, G., Mechlinski, W., and Scaffer, C. P. (1971) Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivative. J. Am. Chem. Soc. 93, 4560-4564.
7. Bolard, J. (1986) How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta 864, 257-304.
8. Hartsel, S. C., and Bolard, J. (1996) Amphotericin B: New life for an old drug. Trends Pharmacol. Sci. 12, 445-449.
9. De Kruijiff, B., and Demel, R. A. (1974) Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and Lecithin liposomes. III. Molecular structure of the polyene antibiotic-cholesterol complex. Biochim. Biophys. Acta 339, 57-70.
10. Baginski, M., Resat, H., and Borowski, E. (2002) Comparative molecular dynamics simulations of amphotericin B-cholesterol/ergosterol membrane channels. Biochim. Biophys. Acta 1567, 63-78.
11. Readio, J. D., and Bittman, R. (1982) Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols. Biochim. Biophys. Acta 685, 219-224.
12. Vertut-Croquin, A., Bolard, J., Chabbert, M., and Gary-Bobo, C. (1983) Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study. Biochemistry 22, 2939-2944.
13. Milhaud, J., Hartmann, M., and Bolard, J. (1989) Interaction of the polyene antibiotic amphotericin B with model membranes: Differences between small and large unilamellar vesicles. Biochimie 71, 49-56.
14. Vertut-Croquin, A., Bolard, J., and Gary-Bobo, C. M. (1984) Enhancement of amphotericin B selectivity by antibiotic incorporation into gel state vesicles. A circular dichroism and permeability study. Biochem. Biophys. Res. Commun. 125, 360-366.
15. Matsumori, N., Yamaji, N., Matsuoka, S., Oishi, T., and Murata, M. (2002) Amphotericin B covalent dimers forming sterol-dependent ion-permeable membrane channels. J. Am. Chem. Soc. 124, 4180-4181.
16. Yamaji, N., Matsumori, N., Matsuoka, S., Oishi, T., and Murata, M. (2002) Amphotericin B dimers with bisamide linkage bearing powerful membrane-permeabilizing activity. Org. Lett. 4, 2087-2089.
17. Matsumori, N., Masuda, R., and Murata, M. (2004) Amphotericin B covalent dimers bearing a tertarate linkage. Chem. Biodiversity 1, 346-352.
18. Matsuoka, S., and Murata, M. (2003) Membrane permeabilizing activity of amphotericin B is affected by chain length of phosphatidylcholine added as minor constituent. Biochim. Biophys. Acta 1617, 109-115.
19. Matsuoka, S., Matsumori, N., and Murata, M. (2003) Amphotericin B-phospholipid covalent conjugates: Dependence of membrane-permeabilizing activity on acyl-chain length. Org. Biomol. Chem. 1, 3882-3884.
20. 31P rotational echo double resonance. Biochemistry 44, 704-710.
21. Matsumori, N., Eiraku, N., Matsuoka, S., Oishi, T., Murata, M., Aoki, T., and Ide, T. (2004) An amphotericin B-ergosterol covalent conjugate with powerful membrane permeabilizing activity. Chem. Biol. 11, 673-679.
22. Matsumori, N., Sawada, Y., and Murata, M. (2005) Mycosamine orientation of amphotericin B controlling interaction with ergosterol: Sterol-dependent activity of conformation-restricted derivatives with an amino-carbonyl bridge. J. Am. Chem. Soc. 127, 10667-10675.
23. Cybulska, B., Gadomska, I., Mazerski, J., Grzybowska, J., Borowski, E., Cheron, M., and Bolard, J. (2000) N-Methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: Monomer/micelle control over selective toxicity. Acta Biochim. Pol. 47, 121-131.
24. Sedlak, M., Buchta, V., Kubicova, L., Simunek, P., Holcapek, M., and Kasparova, P. (2001) Synthesis and characterization of a new amphotericin B-methoxy polyethylene glycol conjugate. Bioorg. Med. Lett. 11, 2833-2835.
25. Chen, W. C., and Bittman, R. (1977) Kinetics of association of amphotericin B with vesicles. Biochemistry 16, 4145-4149.
26. Balon, K., Riebesehl, B. U., and Müller, B. W. (1999) Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm. Res. 16, 882-888.
27. Abraham, T., Lewis, R. N. A. H., Hodges, R. S., and McElhaney, R. N. (2005) Isothermal titration calorimetry studies of the binding of the antimicrobial peptide gramicidin S to phospholipid bilayer membranes. Biochemistry 44, 11279-11285.
28. Zhao, L., Feng, S.-S., Kocherginsky, N., and Kostetski, I. (2007) DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane. Int. J. Pharm. 338, 258-266.
29. Panicker, L. (2008) Interaction of propyl paraben with dipalmitoyl phosphatidylcholine bilayer: A differential scanning calorimetry and nuclear magnetic resonance study. Colloids Surf., B 61, 145-152.
30. Myszka, D. G., and Rich, R. L. (2000) Implementing surface plasmon resonance biosensors in drug discovery. Pharm. Sci. Technol. Today 3, 310-317.
31. Danelian, E., Karlén, A., Karlsson, R., Winiwarter, S., Hansson, A., Löfås, S., Lennernäs, H., and Hämäläinen, M. D. (2000) SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: Correlation with fraction absorbed in humans. J. Med. Chem. 43, 2083-2086.
32. Abdiche, Y. N., and Myszka, D. G. (2004) Probing the mechanism of drug/lipid membrane interactions using Biacore. Anal. Biochem. 328, 233-243.
33. Papo, N., and Shai, Y. (2003) Exploring peptide membrane interaction using surface plasmon resonance: Differentiation between pore formation versus membrane disruption by lytic peptides. Biochemistry 42, 458-466.
34. Mozsolits, H., Wirth, H.-J., Werkmeister, J., and Aguilar, M.-I. (2001) Analysis of antimicrobial peptide interactions with hybrid bilayer membrane systems using surface plasmon resonance. Biochim. Biophys. Acta 1512, 64-76.
35. Hervé, M., Debouzy, J. C., Borowski, E., Cybulska, B., and Gary-Bobo, C. M. (1989) The role of the carboxyl and amino groups of polyene macrolides in their interactions with sterols and their selective toxicity. A phosphorus-31 NMR study. Biochim. Biophys. Acta 980, 261-272.
36. Morton, T. A., Myszka, D. G., and Chaiken, I. M. (1995) Interpreting complex binding kinetics from optical biosensors: A comparison of analysis by linearization, the integrated rate equation, and numerical integration. Anal. Biochem. 227, 176-185.
37. Coutinho, M., and Prieto, M. (1995) Self-association of the polyene antibiotic nystatin in dipalmitoylphosphatidylcholine vesicles: A time-resolved fluorescence study. Biophys. J. 69, 2541-2547.
38. Castanho, M. A. R. B., Prieto, M., and Jameson, D. M. (1999) The pentaene macrolide antibiotic filipin prefers more rigid DPPC bilayers: A fluorescence pressure dependence study. Biochim. Biophys. Acta 1419, 1-14.
39. Bolard, J., Vertut-Croquin, A., Cybulska, B. E., and Gary-Bobo, C. M. (1981) Transfer of the polyene antibiotic amphotericin B between single-walled vesicles of dipalmitoylphosphatidylcholine and egg-yolk phosphatidylcholine. Biochim. Biophys. Acta 647, 241-248.
40. Hubbell, W. L., and McConnell, H. M. (1971) Molecular motion in spin-labeled phospholipids and membranes. J. Am. Chem. Soc. 93, 314-326.
41. Matsuoka, S., and Murata, M. (2002) Cholesterol markedly reduces ion permeability induced by membrane-bound amphotericin B. Biochim. Biophys. Acta 1564, 429-434.
42. Bolard, J., Legrand, P., Heitz, F., and Cybulska, B. (1991) One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry 30, 5707-5715.
43. Matsumori, N., Umegawa, U., Oishi, T., and Murata, M. (2005) Bioactive fluorinated derivative of amphotericin B. Bioorg. Med. Chem. Lett. 15, 3565-3567.
44. Bolard, J., Seigneuret, M., and Boudet, G. (1980) Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B. Lipid state and cholesterol content dependence. Biochim. Biophys. Acta 599, 280-293.
45. Brutyan, R. A., and McPhie, P. (1996) On the one-sided action of amphotericin B on lipid bilayer membranes. J. Gen. Physiol. 107, 69-78.
46. Kasai, Y., Matsumori, N., Umegawa, Y., Matsuoka, S., Ueno, H., Ikeuchi, H., Oishi, T., and Murata, M. (2008) Self-assembled amphotericin B is probably surrounded by ergosterol: Biomolecular interactions as evidenced by solid-state NMR and CD spectra. Chem. - Eur. J. 14, 1178-1185.
47. Fournier, I., Barwicz, J., and Tancrede, P. (1998) The structuring effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers: A differential scanning calorimetry study. Biochim. Biophys. Acta 1373, 76-86.
48. Baran, M., and Mazerski, J. (2002) Molecular modeling of amphotericin B-ergosterol primary complex in water. Biophys. Chem. 95, 125-133.
49. Langlet, J., Berges, J., Caillet, J., and Demarret, J.-P. (1994) Theoretical study of the complexation of amphotericin B with sterols. Biochim. Biophys. Acta 1191, 79-93.
50. Baginski, M., and Borowski, E. (1997) Distribution of electrostatic potential around amphotericin B and its membrane targets. THEOCHEM 389, 139-146.